Lamy, Olivier <br/><br/>
[The necessity of cost-effectiveness analysis in osteoporosis].  [electronic resource] 

 -  Revue medicale suisse  Jun 2007 
 - 1521-5 p.  digital 
<br/><br/> Publication Type: English Abstract; Journal Article 
<br/><br/><label>ISSN: </label>1660-9379 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Bone Density Conservation Agents--economics<br/>Calcium--economics<br/>Cost-Benefit Analysis<br/>Decision Making<br/>Diphosphonates--economics<br/>Female<br/>Fractures, Bone--economics<br/>Health Care Costs<br/>Hip Fractures--economics<br/>Hormone Replacement Therapy--economics<br/>Humans<br/>Male<br/>Markov Chains<br/>Middle Aged<br/>Models, Economic<br/>Organometallic Compounds--economics<br/>Osteoporosis--drug therapy<br/>Parathyroid Hormone--analogs & derivatives<br/>Quality of Life<br/>Selective Estrogen Receptor Modulators--economics<br/>Thiophenes--economics<br/>Vitamin D--economics